α-MSH Stimulates Glucose Uptake in Mouse Muscle and Phosphorylates Rab-GTPase-Activating Protein TBC1D1 Independently of AMPK

PLoS One. 2016 Jul 28;11(7):e0157027. doi: 10.1371/journal.pone.0157027. eCollection 2016.

Abstract

The melanocortin system includes five G-protein coupled receptors (family A) defined as MC1R-MC5R, which are stimulated by endogenous agonists derived from proopiomelanocortin (POMC). The melanocortin system has been intensely studied for its central actions in body weight and energy expenditure regulation, which are mainly mediated by MC4R. The pituitary gland is the source of various POMC-derived hormones released to the circulation, which raises the possibility that there may be actions of the melanocortins on peripheral energy homeostasis. In this study, we examined the molecular signaling pathway involved in α-MSH-stimulated glucose uptake in differentiated L6 myotubes and mouse muscle explants. In order to examine the involvement of AMPK, we investigate -MSH stimulation in both wild type and AMPK deficient mice. We found that -MSH significantly induces phosphorylation of TBC1 domain (TBC1D) family member 1 (S237 and T596), which is independent of upstream PKA and AMPK. We find no evidence to support that -MSH-stimulated glucose uptake involves TBC1D4 phosphorylation (T642 and S704) or GLUT4 translocation.

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism*
  • Animals
  • GTPase-Activating Proteins / metabolism*
  • Glucose / metabolism*
  • Mice
  • Mice, Knockout
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • Phosphorylation
  • Signal Transduction
  • alpha-MSH / pharmacology*

Substances

  • GTPase-Activating Proteins
  • Tbc1d1 protein, mouse
  • alpha-MSH
  • AMP-Activated Protein Kinases
  • Glucose

Grants and funding

The Danish Ministry of Higher Education and Science had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Novo Nordisk provided support in the form of salaries for authors [CLM, BSW and KR]. The effect of the melanocortin system on muscle tissue was of interest for Novo Nordisk at the time of the study as an early exploratory research project. The specific roles of these authors are articulated in the ‘author contributions’ section. Veski Australia, National Health and Medical Research Committee (NHMRC) of Australia (GNT 606662), and Pfizer Australia [MAC] had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.